60 likes | 92 Views
The market is driven by growth in incidence of atrial fibrillation (one of the most common heart rhythm disorder or cardiac arrhythmia), growth in baby boomer generation with high-risk of targeted diseases, and increase in adoption of EP catheter ablation. Rise in focus of the key players toward innovative EP technologies (such as 3D mapping systems, bidirectional duodecapolar diagnostic catheter, remote steering systems, and irrigated-tip RF catheters),<br>Read more: http://bit.ly/2OxeSb7
E N D
Electrophysiology Market Global Opportunity Analysis and Industry Forecasts, 2014 - 2022
Theglobal electrophysiology market size was $3,420 million in 2015, and is expected to reach $8,271 million by 2022, while growing at a CAGR of 13.4% from 2016 to 2022. Electrophysiology (EP) is the branch of cardiology that deals with the diagnosis and treatment of heart rhythm disorders. The EP study helps in the assessment of electrical impulses of the heart and to evaluate abnormal heartbeats. The significant advancement in the EP technologies have enhanced the ability to target the areas of the heart perpetuating that leads to atrial fibrillation (AF).
EP ablation is a minimally invasive procedure, which employs catheters to destroy faulty electrical pathways from heart. The device is useful in removal of the abnormal heart tissues that cause irregular heart rhythms. Radiofrequency and cryoablation types are the most widely used EP ablation catheters, and are expected to register significant market capture with pertinent advancements in the technology. In addition, the number of ablation procedures performed for the treatment of atrial fibrillation is expected to increase substantially in the foresee future. • The atrial fibrillation application accounted for the majority market share in 2015. The cryoablation segment is poised to grow at a CAGR of 15.1% from 2016 to 2022. This growth is attributed to the elimination of disadvantages related with radiofrequency ablation, such as burns of RF, that disrupts the endothelium, tamponades, thromboembolic strokes, and atrial-oesophageal fistula. Moreover, cryoablation catheter ablation and laser ablation is a low-risk process with high success rates, making it a most preferred treatment modality for cardiac arrhythmias.
ELECTROPHYSIOLOGY MARKET KEY BENEFITS • The study provides an in-depth analysis of the global electrophysiology industry with current trends and future estimations to elucidate the imminent investment pockets in the market. • The report provides a quantitative analysis from 2014 to 2022 to enable the stakeholders to capitalize on prevailing market opportunities. • Extensive analysis of the market, by product, helps in understanding the various types of devices used for the treatment of atrial fibrillation and other related cardiac arrhythmias. • Competitive intelligence highlights the business practices followed by leading market players across various geographical regions • Porter’s Five Forces model will interpret the bargaining power of suppliers and buyers, threat of new entrants and substitutes, and competition amongst the key players.
Key players : • St. Jude Medical Inc. • Biosense Webster • Inc. (A Johnson & Johnson Company) • Boston Scientific Corporation • Medtronic Inc. • GE Healthcare (Division of General Electric Co.) • Siemens AG • Medtronic plc • Philips Healthcare (A Division of Koninklijke Philips N.V.) • Biotronik SE & Co.KG • Microport Scientific Corporation • Abbott Laboratories.
Electrophysiology Market by Product (EP Ablation Catheters, EP Laboratory Devices, EP Diagnostic Catheters, Access Devices), Indication (Atrial Fibrillation, Atrial Flutter, Atrioventricular Nodal Reentry Tachycardia, Wolff-Parkinson-White Syndrome) - Global Opportunity Analysis and Industry Forecasts, 2014 - 2022